Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinicopathological and molecular features of acquired cystic disease-associated renal cell carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41644424 | PubTator, text mining | PubMed |
| KMT2C Loss Promotes NF2-Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling. | Adv Sci (Weinh) | 2026 | 41642951 | PubTator, text mining | PubMed |
| Harnessing AACR Project GENIE to Define the Molecular Features of Desmoplastic Small Round Cell Tumor. | Curr Issues Mol Biol | 2026 | 41614915 | PubTator, text mining | PubMed |
| Metastatic organotropism in peritoneal metastasis: Paget's hypothesis revisited. | Clin Exp Med | 2026 | 41609906 | PubTator, text mining | PubMed |
| A tryptophan-phenylalanine binding motif for the histone methyltransferases MLL4 and MLL3. | J Biol Chem | 2026 | 41581869 | PubTator, text mining | PubMed |
| Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review). | Oncol Rep | 2026 | 41574717 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. | Hemasphere | 2026 | 41560848 | PubTator, text mining | PubMed |
| A novel oncogenic nonsense mutation of SMARCA4 and genetic characteristic analysis of SMARCA4 (BRG1)-deficient undifferentiated tumor of the bladder. | Virchows Arch | 2026 | 41555058 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| DNA methylation signature of cognitive reserve moderates CSF tau pathology in prodromal Alzheimer's disease. | Res Sq | 2026 | 41542061 | PubTator, text mining | PubMed |
| Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degeneration via autophagy and ageing in nucleus pulposus cells. | Noncoding RNA Res | 2026 | 41536620 | PubTator, text mining | PubMed |
| The dynamics of mutational selection in cutaneous squamous carcinogenesis. | Commun Biol | 2026 | 41526710 | PubTator, text mining | PubMed |
| A comparative analysis of mutational profiles between triple-negative breast cancer and non-triple-negative breast cancer. | Discov Oncol | 2026 | 41526581 | PubTator, text mining | PubMed |
| Mutations in histone lysine methyltransferase genes are associated with autoimmune cytopenias: a single-center study. | Blood Vessel Thromb Hemost | 2026 | 41438733 | PubTator, text mining | PubMed |
| Stapled histone H3 tails are super-substrates for lysine methyltransferase SETD7. | Chem Sci | 2026 | 41383456 | PubTator, text mining | PubMed |
| Somatic alterations of genitourinary malignancy of Chinese population based on tumor NGS data. | Urol Oncol | 2026 | 41352999 | PubTator, text mining | PubMed |
| Clinicopathological spectrum of non-sinonasal intestinal-type adenocarcinomas of the head and neck: Systematic review of case reports, case series, and cross-sectional studies. | Med Oral Patol Oral Cir Bucal | 2026 | 41273750 | PubTator, text mining | PubMed |
| KMT2C mutations in breast cancer: molecular mechanisms of cancer promotion, clinical significance, and potential as biomarkers. | Crit Rev Oncol Hematol | 2026 | 41203099 | PubTator, text mining | PubMed |
| MEX3A-mediated super-enhancer RNA m6A methylation promotes aggressiveness of breast cancer via regulating RBM15B/IGF2BP3/KMT2C signaling. | Transl Oncol | 2026 | 41161249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=5